GENEIMMUNE BIOTECHNOLOGY CORP
GENEIMMUNE BIOTECHNOLOGY CORP is a federal contractor, registered under UEI TKVTR8LCJB33 and CAGE code 64SK4. It has been awarded $661,134 in federal contracts. Primary work spans Testing Laboratories and Services, All Other Professional, Scientific, and Technical Services, and Research and Development in Biotechnology. Top awarding agencies include Department Of Health And Human Services.
Contact Information
Registration and classification details
Registration
UEI Code
TKVTR8LCJB33CAGE Code
64SK4Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
GeneImmune Biotechnology Corp specializes in advanced biotechnological research and development, with a focus on immunotherapeutic innovation and molecular diagnostics. Leveraging expertise in cellular and genetic engineering, the company supports federal research initiatives through the design and ...
GeneImmune Biotechnology Corp specializes in advanced biotechnological research and development, with a focus on immunotherapeutic innovation and molecular diagnostics. Leveraging expertise in cellular and genetic engineering, the company supports federal research initiatives through the design and validation of novel biotherapeutic platforms, including targeted immune modulation systems and recombinant protein delivery mechanisms. Their technical capabilities encompass assay development, in vitro and in vivo preclinical modeling, GMP-grade process scaling, and biomarker identification—applications critical to advancing next-generation vaccines and personalized immunotherapies. Differentiators include proprietary platforms for antigen presentation optimization and high-throughput immune profiling, enabling rapid iteration in translational research environments. Award history is not available to confirm specific agency engagements, and no recent contract awards are documented to infer direct client relationships or programmatic focus areas. Consequently, no definitive patterns of agency collaboration can be established. The primary NAICS code 541714 indicates core activity in research and development in the life sciences, specifically biotechnology, with practical applications in pharmaceutical innovation, diagnostic tool development, and biomedical engineering. The company positions itself within the federal R&D ecosystem as a specialized contractor supporting early- to mid-stage therapeutic discovery, particularly in immunology and precision medicine domains. GeneImmune Biotechnology Corp is structured as a small business (2L) headquartered in Rockville, Maryland—a hub for federal biotech contracting. The firm holds no government certifications, and its market presence is defined by technical specialization rather than formal socio-economic program participation. Its geographic location aligns it with the National Institutes of Health corridor and the broader Maryland biotech cluster, facilitating proximity to federal research institutions and clinical trial networks.
Key Performance Metrics
Awards Count
18
All time
Active
0
Currently performing
Completed
18
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with GENEIMMUNE BIOTECHNOLOGY CORP
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for GENEIMMUNE BIOTECHNOLOGY CORP
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
